Published in Laryngoscope on August 01, 1990
The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol (2003) 0.92
Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy. Eur Arch Otorhinolaryngol (2015) 0.75
A prognostic index in primary breast cancer. Br J Cancer (1982) 7.35
The number of patients required in a clinical trial. Br J Radiol (1971) 3.85
Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol (1971) 3.53
Confirmation of a prognostic index in primary breast cancer. Br J Cancer (1987) 3.29
A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. Int J Radiat Oncol Biol Phys (2001) 2.67
Relationship of oestrogen-receptor status to survival in breast cancer. Lancet (1979) 2.55
Relationship between primary breast tumor receptor status and patient survival. Cancer (1980) 2.49
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. Br J Cancer (1982) 2.39
Radiosensitizers of hypoxic cells in solid tumors. Cancer Treat Rev (1976) 2.33
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int J Radiat Oncol Biol Phys (1992) 2.24
The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys (1995) 2.05
Idealized versus realized overall treatment times. Int J Radiat Oncol Biol Phys (1994) 2.02
Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res (1978) 1.95
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer (2007) 1.94
Cardiac doses in post-operative breast irradiation. Radiother Oncol (1992) 1.88
Long-term survival of women with breast cancer. Lancet (1984) 1.86
Cell kinetic measurements in prostate cancer. Int J Radiat Oncol Biol Phys (1997) 1.83
Reading the prognosis of the individual with breast cancer. Eur J Cancer (2007) 1.83
A 15-year follow-up study of patients treated for carcinoma of the breast. Br J Radiol (1968) 1.83
The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation. Radiat Res (1976) 1.81
Treatment of stage-II carcinoma of the female breast. Lancet (1971) 1.76
Prognostic factors in breast cancer -- the formation of a prognostic index. Clin Oncol (1979) 1.74
Selective boosting of tumor subvolumes. Int J Radiat Oncol Biol Phys (2000) 1.68
Vulnerability of developing brain. VII. Permanent deficit of neurons in cerebral and cerebellar cortex following early mild undernutrition. Exp Neurol (1971) 1.65
Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol. Int J Radiat Oncol Biol Phys (1995) 1.64
Results of treatment of female breast cancer in the Cambridge area 1960-71. Br J Cancer (1979) 1.53
North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol (1998) 1.51
Balsam-related systemic contact dermatitis. J Am Acad Dermatol (2001) 1.50
Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol (1990) 1.48
Caution on the use of altered fractionation for nasopharyngeal carcinoma. Radiother Oncol (1999) 1.43
Alpha, beta, and surviving fraction. Int J Radiat Oncol Biol Phys (1992) 1.40
Psychological response to breast cancer and 15-year outcome. Lancet (1990) 1.40
Peristomal allergic contact dermatitis due to Gantrez in Stomahesive paste. J Am Acad Dermatol (2000) 1.40
Time- and dose-related changes in the white matter of the rat brain after single doses of X rays. Br J Radiol (1988) 1.40
Re-analysis of the time factor in local control by radiotherapy of T3T4 squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys (1991) 1.38
Oestrogen-receptor status and sites of metastasis in breast cancer. Br J Cancer (1981) 1.38
A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation (1997) 1.38
Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug. Br J Cancer (1974) 1.35
The effect of irradiating a transplanted murine lymphosarcoma on the subsequent development of metastases. Br J Cancer (1973) 1.33
Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. East Mediterr Health J (2007) 1.33
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol) (1996) 1.31
Vulnerability of developing brain. I. Some lasting effects of x-irradiation. Exp Neurol (1970) 1.30
Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy. Lancet (1981) 1.29
Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (1998) 1.26
Mental attitudes to cancer: an additional prognostic factor. Lancet (1985) 1.25
Death certification in cancer of the breast. Br Med J (Clin Res Ed) (1984) 1.25
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. Br J Cancer (1987) 1.23
A murine model of lip epidermal/mucosal reactions to X-irradiation. Radiother Oncol (1983) 1.21
Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index. Lancet (1985) 1.20
A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys (1985) 1.18
Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. Int J Radiat Oncol Biol Phys (1977) 1.16
Changes in mouse blood pressure, tumor blood flow, and core and tumor temperatures following nembutal or urethane anesthesia. Radiology (1976) 1.15
The cured group in a series of treated breast cancer patients. Br J Radiol (1968) 1.15
The nature of latent cerebral irradiation damage and its modification by hypertension. Br J Radiol (1970) 1.14
Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys (2000) 1.14
Development of blood vessel-related radiation damage in the fimbria of the central nervous system. Int J Radiat Oncol Biol Phys (1990) 1.12
Letter: The late vascular effects of radiation. Br J Radiol (1974) 1.10
Repair in mouse lung between multiple small doses of X rays. Radiat Res (1983) 1.09
Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. Br J Radiol (2004) 1.09
Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 1.09
The importance of implantation site in cerebral carcinogenesis in rats. Cancer Res (1969) 1.09
Summary of general discussion on radiotherapeutic aspects of the clinical application of fast neutrons. Eur J Cancer (1971) 1.08
Fractionation factors for late effects in head and neck cancers. Int J Radiat Oncol Biol Phys (1992) 1.07
Review: total doses in fractionated radiotherapy--implications of new radiobiological data. Int J Radiat Biol Relat Stud Phys Chem Med (1984) 1.06
Role of radiotherapy following total mastectomy in patients with early breast cancer. The Closed Trials Working Party of the CRC Breast Cancer Trials Group. World J Surg (1994) 1.05
The incidence of lung metastases in C3H mice after treatment of implanted solid tumours with x-rays or surgery. Br J Cancer (1974) 1.05
Protocol for X-ray dosimetry in radiobiology. Int J Radiat Biol (2001) 1.05
Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas. Eur J Cancer (2000) 1.04
Effects of single doses of radiation on cardiac function in the rat. Radiother Oncol (1985) 1.04
Shoulder movement after the treatment of early stage breast cancer. Clin Oncol (R Coll Radiol) (1998) 1.04
The curability of breast cancer. World J Surg (1977) 1.04
Hypoxic cell sensitisers in radiotherapy. Lancet (1976) 1.03
Current aspects of radiobiology as applied to radiotherapy. Clin Radiol (1972) 1.03
Skin reactions in mice after multifraction x-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1974) 1.03
Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. Br J Cancer Suppl (1978) 1.02
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations. Int J Radiat Oncol Biol Phys (1992) 1.02
Effect of previous x-irradiation on the response of brain to injury. Nature (1967) 1.02
Confirmation of improved local-regional control with altered fractionation in head and neck cancer. Int J Radiat Oncol Biol Phys (2000) 1.01
Dose-response relationships for human tumors: implications for clinical trials of dose modifying agents. Int J Radiat Oncol Biol Phys (1984) 1.01
Changes in the microcirculation of normal tissues after irradiation. Int J Radiat Oncol Biol Phys (1978) 1.00
The predictive value of histological classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypopharynx compared with the survival of patients. Histopathology (1991) 0.99
Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. Clin Oncol (R Coll Radiol) (2009) 0.99
The measurement of skin lymph flow by isotope clearance--reliability, reproducibility, injection dynamics, and the effect of massage. J Invest Dermatol (1990) 0.99
Clinical trial of radiosensitizers, including synkavit and oxygen inhaled at atmospheric pressure. Acta Radiol Ther Phys Biol (1965) 0.99
The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (1997) 0.99
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results. Br J Cancer (1991) 0.98
Late behavioural and neuropathological effects of local brain irradiation in the rat. Behav Brain Res (1998) 0.98
The measurement of blood perfusion in experimental tumors by uptake of 86Rb. Cancer Res (1974) 0.98
Vascular irradiation damage: its cellular basis and likely consequences. Br J Cancer Suppl (1986) 0.98
The late effects of artificial menopause by X-radiation. Br J Radiol (1969) 0.98
Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour. Br J Cancer (1977) 0.97
Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Ther (2003) 0.97
The correction of intestinal microcolony counts for variation in size. Int J Radiat Biol Relat Stud Phys Chem Med (1981) 0.97
A review of hypoxic cell radiosensitization in experimental tumors. Pharmacol Ther (1979) 0.97
A drug for improved radiosensitization in radiotherapy. Br J Cancer (1980) 0.96
Repair in mouse lung for up to 20 fractions of X rays or neutrons. Br J Radiol (1985) 0.96